Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K243291
    Date Cleared
    2025-01-17

    (91 days)

    Product Code
    Regulation Number
    884.2675
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Goldtrace Fetal Spiral Electrode (FSE) (CNS000004)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Goldtrace FSE is indicated for patients requiring continuous electronic intrapartum monitoring of the fetal heart rate during labor and delivery.

    Device Description

    Goldtrace FSE is a sterile, single use device transmitting the fetal ECG signal for continuous electronic intrapartum monitoring. The device consists of gold-plated stainless steel spiral needle electrode that attaches to the fetal presenting part. The device includes a reference plate to measure the reference voltage level in the amniotic fluid. A guide tube and drive tube are used for application to the fetal presenting part. The subject device is connected to a compatible monitor (e.g., Philips Avalon FM30) via Philips DECG Reusable Legplate adaptor cable to provide a fetal ECG signal to the monitor. The subject device does not perform any conversion, analysis, quantification, or modifications to the fetal ECG.

    AI/ML Overview

    This document is a 510(k) Summary for the Goldtrace Fetal Spiral Electrode (FSE), which is a medical device. The summary outlines the device's indications for use, its comparison to a predicate device, and the non-clinical performance data provided to support its substantial equivalence.

    Here's an analysis to answer your questions:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state "acceptance criteria" with numerical targets for the comparative performance testing. Instead, it states that the devices are "equivalent" and "perform equally."

    For other performance areas, the acceptance criteria are implied by adherence to recognized standards and successful completion of tests.

    Acceptance Criteria CategoryReported Device Performance
    Biocompatibility- Cytotoxicity: Non-cytotoxic (ISO 10993-5:2009)
    - Sensitization: Non-sensitizing (ISO 10993-10:2010)
    - Irritation: Non-irritating (ISO 10993-10:2010)
    - Systemic Toxicity: Not systemically toxic (ISO 10993-11:2006)
    - Pyrogenicity: Non-pyrogenic (USP38-NF33:2015 )
    Electrical Safety & EMCComplies with IEC 60601-1:2020 and IEC 60601-1-2:2014 + AMD:2020. Also tested (with deviations consistent with device's intended use) according to ANSI/AAMI EC12:2000/(R)2015 and ANSI/AAMI EC53:2013/(R)2020.
    Sterility & Shelf-Life- Sterilization: Validated per ISO 11135:2014 and FDA guidance.
    - Transportation: Passed simulated transportation and package integrity testing per ASTM D4169-22.
    - Shelf-life: 5 years (accelerated aging per ASTM F1980:21, including package integrity tests: dye penetration per ASTM F1929-15, seal strength per ASTM F88/F88M-21, visual assessment per ASTM F1886/F1886M-16).
    Mechanical Testing- Pull Apart Test: Demonstrated successful performance for Goldtrace FSE connector and Legplate.
    - Three-point Bend Test: Demonstrated material consistency and pliability for drive tube and guide tube.
    Comparative PerformanceGoldtrace FSE and predicate device (K030691) are equivalent in electrical properties, in their ability to transmit fetal ECG signals, and perform equally when used with Philips Avalon FM30 fetal monitor.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document is a 510(k) summary for non-clinical performance data. It does not provide details about clinical studies, test set sample sizes, or data provenance in terms of patient data. The "test sets" for the non-clinical tests would refer to the number of device units tested for each specific test (e.g., how many devices were tested for biocompatibility, electrical safety, mechanical strength), which is not specified in this summary. The data provenance is from non-clinical testing, likely conducted by the manufacturer or accredited labs on their behalf. The country of origin for the data is not explicitly stated, but the manufacturer is Neoventa Medical AB in Sweden.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This document is about a hardware medical device (fetal spiral electrode) and its non-clinical performance. It does not involve interpretation of medical images or data by human experts for establishing ground truth in the way an AI algorithm for diagnostics would. Therefore, this question is not applicable to the information provided. The ground truth for the device's function is its ability to transmit fetal ECG signals accurately, which is assessed through instrumental measurements rather than expert consensus on medical findings.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    As this document describes non-clinical performance testing of a hardware device, there is no adjudication method involving multiple human readers as would be typical for clinical studies or AI diagnostic algorithms. Performance is assessed against technical standards and comparisons to a predicate device via instrumental measurements.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No, an MRMC comparative effectiveness study was not done. This is a 510(k) summary for a hardware medical device (fetal spiral electrode), not an AI-powered diagnostic tool. The document focuses on the device's physical and electrical performance, and its equivalence to a predicate device, not on human reader performance with or without AI assistance.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable. The Goldtrace Fetal Spiral Electrode is a hardware device described as transmitting a fetal ECG signal to a monitor. The document explicitly states: "The subject device does not perform any conversion, analysis, quantification, or modifications to the fetal ECG." It does not contain an algorithm for standalone performance.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    For this device, the "ground truth" for its performance is established by:

    • Adherence to recognized technical standards: This includes biocompatibility, electrical safety, sterility, and mechanical integrity standards (e.g., ISO, IEC, ASTM, USP). The "truth" is whether the device meets the specifications and limits defined by these standards.
    • Functional equivalence to a predicate device: For the comparative performance testing, the ground truth is that the device should achieve the "same" or "equivalent" performance in transmitting fetal ECG signals as the legally marketed predicate device (K030691) when used with a compatible monitor. This equivalence is assessed through direct electrical and signal integrity measurements, not a human-derived ground truth.

    8. The sample size for the training set

    This question is not applicable. This device is a hardware medical device and does not involve AI algorithms that require a "training set."

    9. How the ground truth for the training set was established

    This question is not applicable, as there is no training set for this hardware device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1